NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Medpace Reports Fourth Quarter And Full Year 2016 Results February 27, 2017 Top 10 R&D Scientist Skills in Demand April 26, 2017 FDA Calls Omeros' Kidney Disorder Drug a Breakthrough June 12, 2017
